urotoxic side effects , especially hemorrhagic cystitis , have so far been a limiting factor in the therapeutic use of cyclophosphamide ( endoxan ) , ifosfamide ( holoxan ) , and trofosfamide ( ixoten ) .
C0020823
ifosfamide
C0733930
holoxan